摘要
目的 :观察稳心颗粒对慢性肾衰合并心律失常的疗效。方法 :6 6例慢性肾衰合并心律失常患者随机分为两组 ,分别给予稳心颗粒和心律平 ,余对症治疗相同 ,4周后观察两组对心律失常的治疗效果。结果 :稳心颗粒组患者临床症状改善明显优于对照组 ,心电图改善情况无明显差异。结论 :稳心颗粒是治疗慢性肾衰合并心律失常的一种有效且副作用小的新型药物。
Objective:To study the curative effects of wenxinkeli on chronic renal failure(CRF)patients with arrhythmia.Methods: The study was carried out among 66 cases who were divided into two groups.The observation group was given wenxinkeli,another group was given hydrochloride ,4 weeks later the curative effects were compared. Results:The curative effects for the clinical symptom in observation group were obviously better than those of control group,there was no obvious difference among them on electrocardiogram. Conclusion: Wenxinkeli is a kind of valid and less side-effect new medicine to cure CRF with arrhythmia.
